IWC
STOK icon

Integrated Wealth Concepts’s Stoke Therapeutics STOK Stock Holding History

Integrated Wealth Concepts’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25K Buy
+38
New +$1.22K ﹤0.01% 5481

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Integrated Wealth Concepts's STOK Position: Q2 2026 in Review

Integrated Wealth Concepts opened a new position in Stoke Therapeutics (STOK) in Q2 2026: 38 shares worth $1.25K. The stake represents ﹤0.01% of the portfolio and ranks #5481 among its holdings.

197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Integrated Wealth Concepts held 38 shares of Stoke Therapeutics worth $1.25K as of Q2 2026.
  • Stoke Therapeutics was a new Integrated Wealth Concepts position in Q2 2026.
  • Stoke Therapeutics made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #5481 holding.
  • 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.